•  •  Dark Mode

Your Interests & Preferences

I am a...

law firm lawyer
in-house company lawyer
litigation lawyer
law student
aspiring student
other

Website Look & Feel

 •  •  Dark Mode
Blog Layout

Save preferences

Nishith Desai’s animal healthcare player SeQuent bought by AZB’s Carlyle for $209m

The US based private equity firm The Carlyle Group has agreed to acquire 74% stake in SeQuent Scientific Limited, the largest pure-play animal healthcare company in India, for $210 million (Rs.1587 crore), company said on Friday. Carlyle will buy shares at a price of Rs.86 apiece.

The Economic Times

Nishith Desai Associates advised SeQuent and the promoters of Sequent, including Arun Kumar and family with M&A co-head and leader Simone Reis, leader Shreyas Bhushan and senior lawyer Amudavalli Kannan.

AZB & Partners partner Sayak Maity acted for Carlyle.

White & Case also acted for Carlyle.

2020-05-08

Deal value: $210m (Rs 1,580 crore)

This deal report is based on a firm's press release and may be only partially complete. Some firms or names of advisers may be therefore be missing.

Click to show 2 comments
at your own risk
(alt+c)
By reading the comments you agree that they are the (often anonymous) personal views and opinions of readers, which may be biased and unreliable, and for which Legally India therefore has no liability. If you believe a comment is inappropriate, please click 'Report to LI' below the comment and we will review it as soon as practicable.